Trinitas Capital Management LLC

Item 5 Fees and Compensation

General

TCM receives management fees in connection with the investment management services it provides to each
of the CLOs and is also permitted to receive performance fees, carried interest, or other incentive
compensation related to the performance of each CLO. Such management fees, carried interest,
performance fees, or other compensation will generally be established at the beginning of the advisory
relationship with each CLO. Specific details of such compensation and its method of calculation will be
set out in the offering materials, disclosure documents, collateral management agreements, and the
constituent documents of each CLO. Such compensation, once the relevant CLO is established, is generally
not negotiable, though TCM has, and may in the future, enter into strategic partnerships, side letter
agreements, or other arrangements with specific investors in the CLOs whereby such investors receive
direct or indirect reductions of management fees or other compensation payable with respect to their
investments managed by TCM, in each case consistent with the constituent documents of each CLO.

Management Fees

TCM charges management fees at an annual rate of up to approximately 0.50% of the defined asset value
calculated for each CLO for which it provides investment advisory services. Such management fees will
generally be structured with a portion of such fees payable as a senior management fee and a portion payable
as a subordinated management fee. Management fees will typically be payable quarterly in arrears and will
be dependent in part on certain cash distribution constraints set forth in the constituent documents for each
CLO. The specific management fees, payment terms, and calculation and valuation methods for each CLO
will be described in detail in the offering documents for each CLO.

Performance-Related Compensation

TCM is permitted to also receive performance fees, carried interest, or other incentive compensation from
the CLOs. Such performance fees are expected to constitute an amount of up to 20% of the CLO’s excess
cash flow in excess of the relevant preferred return or hurdle rate for each CLO. The specific performance
fees, payment terms, and calculation and valuation methods for each CLO will be described in detail in the
offering documents for each CLO. For more information on performance based compensation see Item 6 –
Performance Based Fees and Side-by-Side Management.

Other Expenses

In accordance with the terms of the TCM’s collateral management agreements with the CLOs, the CLOs
will generally reimburse TCM for certain out-of-pocket expenses related to the services provided by TCM
and third parties to the funds. Among other things, the CLOs may reimburse TCM for fees and expenses
relating to establishing the fund, accountants, rating agencies, loan pricing services, software providers,
custodial fees, commissions, trade settlement fees, legal and consultant fees and expenses, software or
information technology fees and expenses of TCM primarily related to the provision of services to the client
account, exchange fees, bank service fees, income withholding or transfer taxes, and fees of other service
providers. To the extent such expenses relate to more than one CLO managed by TCM, such expenses will
be allocated among each applicable CLO in a fair and equitable manner, typically based on the net assets
of each CLO for the applicable allocation period.

The CLOs will typically pay other fees in connection with TCM’s advisory services relating to the
establishment or ongoing operation of the funds. These additional fees may include those of the CLO’s
trustee, collateral administrator, administrator, accountants, lawyers, rating agencies, and regulators. The
CLOs will also bear any brokerage commissions, mark ups/downs or other transaction fees for the CLO’s
investment and brokerage transactions. As noted above, the CLOs bear expenses related to portfolio
transactions. Please see Item 12 – Brokerage Practices for a discussion of TCM’s brokerage practices.

Item 7 Types of Clients

TCM was formed to provide investment advisory services to CLOs. Investment in the CLOs is generally
only available to institutional investors and certain high net worth individuals that are “accredited investors”
and “qualified purchasers” or non- “U.S. persons” within the meaning of the Securities Act of 1933 (the
“Securities Act”) and the 1940 Act, as applicable. The CLOs may have a specified minimum investment
amount set forth in their offering documentation. These minimum amounts may be subject to discretion on
the part of TCM to permit a smaller amount with respect to any investor in a particular CLO. TCM
anticipates that a broad range of institutional investors and high net worth individuals meeting the criteria
set forth above will invest in CLOs managed by TCM.

This Brochure is not an offer (or solicitation of an offer) to invest in CLOs or otherwise obtain TCM’s
advisory services. Prior to investing in any CLO, an investor should review the relevant offering materials
for important information concerning the objectives, policies, strategies, risks, fees, and other important
information regarding a CLO as set forth in the prospectus, confidential private offering circular or private
offering memorandum for such CLO. Although this publicly available Brochure describes investment
advisory services and products of TCM, persons who receive this Brochure should be aware that it is
designed solely to provide information about TCM as necessary to respond to certain disclosure obligations
under the Advisers Act. As such, the information in this Brochure may differ from information provided in
the relevant governing documents for the CLOs. More complete information about each CLO is included
in its relevant governing documents. To the extent that there is any conflict between discussions herein and
similar or related discussions in any governing documents for a CLO, the relevant governing documents
shall govern and control.